Please provide your email address to receive an email when new articles are posted on . GLP-1s show benefit in patients with HF, regardless of obesity. GLP-1s raise heart rate, which is linked to ...
NEW YORK (AP) — The New York City Marathon made history on Sunday with a course record set in the women’s competition and the closest race ever on the men’s side, which was decided by a fraction of a ...
It's no secret that triple-A game development is becoming unsustainably expensive, so to support major titles, big studios should look to diversify the scale of their productions. That's according to ...
DC Comics is having a banner year. Beginning last year, the brand new Absolute imprint, which rebooted the characters in grittier, darker, and totally different ways, proved a massive hit. The ...
Semaglutide and tirzepatide significantly reduced hospitalization and mortality risk in HFpEF patients compared to sitagliptin, with reductions of 42% and 58%, respectively. The study utilized ...
Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published Aug. 31 in JAMA.
With the price of weight-loss injection Mounjaro rising by 170 per cent next month – the highest dose going from £120 to £330 – many who have been relying on the jabs to shift excess pounds may have ...
According to expert presenters at the American Society of Preventive Cardiology’s 2025 Congress on Cardiovascular Disease Prevention, recent studies have shown significant benefit to GLP-1 inhibitors ...
GLP-1 inhibitors significantly reduce cardiovascular events and mortality, with promising results in weight reduction and heart failure symptom improvement. Clinicians should incorporate GLP-1s into ...
DEAR DR. ROACH: My 66-year-old husband recently received a diagnosis of heart failure with preserved ejection fraction. He is 5 feet, 7 inches tall, and weighs 270 pounds. He is treating his fluid ...
Exciting news for Batman fans! 2025 is shaping up to be a big year for DC's flagship comic. Whilst the comic's current writer has just ended his run with Batman #157, it isn't the end. DC Comics have ...
Several companies have switched to DeepSeek to save costs DeepSeek's structural impact pervasive, executives say Startups fast to switch, large firms to watch and wait GOTHENBURG, Feb 3 (Reuters) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback